S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

The plant will produce the key ingredients needed to make the anti-retroviral drugs that have turned AIDS into a , rather than a in a nation where 5.6 million people have HIV.

"This joint venture, named Ketlaphela, will establish the first pharmaceutical plant to manufacture for anti-retroviral medicines in South Africa," Science Minister Naledi Pandor told journalists.

South Africa will invest 1.1 billion rands, while Lonza will put 500 million rands into the plant, whose name means "I will survive" in Sotho, she said.

"Lonza's high Swiss standards plus their superb track record of establishing and maintaining successful commercial operations in developing countries, make them a valuable and desirable partner," Pandor said.

The new plant will help stabilise the price of drugs used to fight AIDS, as South Africa currently imports the main ingredients needed.

The plant will create about 2,600 jobs once it's running in 2016, he added. About 3,800 people will be employed for its construction.

South Africa has the world's largest programme, serving 1.3 million people.

The treatment programme has already made gains in combating the epidemic, but the numbers of people needing drugs will keep growing as more and more people begin a lifetime on the medicines.

Related Stories

South Africa unveils plan to halve HIV infections

date Dec 01, 2011

President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

Anti-AIDS drugs slow deaths in S.Africa: study

date Mar 11, 2011

South Africa's AIDS deaths have fallen by nearly 25 percent due to scaled up access to life-saving drugs, which the government for years had refused to provide, new research has shown.

S. African to double HIV patient treatment

date Dec 14, 2010

(AP) -- South Africa's health minister says he has brought down the cost of HIV drugs by 53 percent, enabling the government to treat twice as many patients in the next two years.

South Africa unveils space agency

date Dec 09, 2010

South Africa unveiled its national space agency on Thursday, aiming to become a leader in earth observation technology across the continent in 10 years, the minister of science and technology said.

Recommended for you

Indiana HIV outbreak, hepatitis C epidemic sparks US alert

date Apr 24, 2015

Federal health officials helping to contain an HIV outbreak in Indiana state issued an alert to health departments across the U.S. on Friday, urging them to take steps to identify and track HIV and hepatitis C cases in an ...

Why are HIV survival rates lower in the Deep South than the rest of the US?

date Apr 22, 2015

The Deep South region has become the epicenter of the US HIV epidemic. Despite having only 28% of the total US population, nine states in the Deep South account for nearly 40% of national HIV diagnoses. This region has the highest HIV diagnosis rates and the highest number of people living with HIV of any ...

A bad buzz: Men with HIV need fewer drinks to feel effects

date Apr 20, 2015

Researchers at Yale and the VA Pittsburgh Healthcare System compared the number of drinks that men with HIV infection, versus those without it, needed to get a buzz. They found that HIV-infected men were more sensitive to ...

Research informs HIV treatment policy for inmates

date Apr 16, 2015

A national, five-year study of care for inmates with HIV brought strangers together, produced policy change in the Delaware Department of Corrections and documented the importance of good communication and ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.